Home › Bile Duct Cancer (Cholangiocarcinoma) › Michigan › Detroit
Bile Duct Cancer (Cholangiocarcinoma) clinical trials in Detroit, MI
4 studies for Bile Duct Cancer (Cholangiocarcinoma) are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
RecruitingPhase 3
- Karmanos Cancer Center (Site 109), Detroit
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RecruitingPhase 1/2
- Barbara Ann Karmanos Cancer Center, Detroit
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- Henry Ford Cancer Center, Detroit
Bile Duct Cancer (Cholangiocarcinoma) trials in other cities
- Houston, TX13 studies
- New York City, NY11 studies
- Boston, MA8 studies
- Rochester, MN7 studies
- Arlington, VA7 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Columbus, OH6 studies
- Cleveland, OH6 studies
- Queens, NY5 studies
- Edison, NJ5 studies
- Grand Rapids, MI5 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.